EASL Studio S4E1 - Hepatitis B elimination
EASL Studio S4e2 - YI Choice: how to build consortia and registries
S4E1Promo - HBV Elimination how far are we?
EASL Studio S4E12 - NAFLD and NASH – moving beyond the liver biopsy – where are we now?
EASL Studio S4E10 - Ascites: New solution for an old problem
EASL Studio S4E3 - A 360 approach to beat alcohol-related liver disease
EASL Studio - Season 2, Episode 4 - Betablockers in cirrhosis: Has Baveno consensus gone too far?
EASL Studio S4E4 - JHEP Live: Is the term ‘decompensated cirrhosis’ outdated?
EASL Studio – S3E9 – JHEP Live: ASOs vs siRNAs for treating chronic HBV: Who will be the winner?
EASL Studio - S2 E17 - EASL Haemochromatosis Guidelines 2022
EASL Studio S4E5 - AI for Dummies
Achieving WHO's 2030 Hep B & C Elimination Goals -What Progress Has Been Made & What More is Needed?
EASL Studio at ILC 2022 - Thu 23 June - Midday Talks on Improving Liver Cancer Care & Prevention
EASL Studio - Special Edition - Live from the Viral Hepatitis Elimination Conference 2022
EASL Studio S3E14 - The future of hepatology
EASL Studio - S3E15 - Chronic portal vein thrombosis
Prof. Sahar Maklad - Introduction to a case of HBV
Clinical spectrum of liver disease in Africa | Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD
S4E4 Promo - Towards a new definition of decompensation in patients with cirrhosis
EASL highlights 2017 | Jürgen Rockstroh, MD
S4E3 Promo - A 360 approach to beat alcohol-related liver disease
EASL Guidelines on Viral Hepatitis Elimination - Mojca Matičič, MD, PhD
S4E6 Promo - Regenerating the liver graft with a machine
S4E9 Promo - YI Choice: Gender equality in academics - reducing the gap
EASL-WHA (World Hepatitis Alliance) joint workshop. The AFRO region by Dr. Danjuma Adda.
